TI - Prognostic Markers in the Treatment of Abiraterone Acetate + Prednisolone and Enzalutamide in Castration-Resistant Metastatic Prostate Cancer
PT - Journal Article
DP - 2022
TA - EJMI
PG - 45-49
VI - 6
IP - 1
AID - 2022.22832 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2022.22832
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2022 6(1): 45